Idifarma: Ardena buys Spain's Idifarma in move to capitalize on emerging biotech segment
Ardena has acquired Idifarma, a contract manufacturer of niche and highly potent generic and innovative drugs, from Suanfarma; the deal enables it to expand across Southern Europe and supports its strategy to become a leading global CDMO.
Read full article »
Idifarma is a Spain-based CDMO that provides services including GMP manufacturing, quality control, formulation and analytical development for the pharmaceutical sector.
Read more